Pregabalin lactose conjugates
US7022678B2 · kind B2 · utility
5Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2002 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | May 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with the present invention, there is provided pregabalin lactose conjugate compounds.Also provided as part of the present invention is a novel method of central nervous system disorders or diseases including seizure disorders, pain, depression, anxiety, sleep disorders, consumptive disorders, psychosis, tardive dyskinesia, Huntington's disease, or Parkinson's disease in a subject by administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.